Comprehensive panel boosts GIST diagnosis sensitivity: Rondell Graham, M.B.B.S.

from Answers from the Lab · host Mayo Clinic Laboratories

(00:31) Can you please provide us a little bit of background about yourself?(01:29) Can you give us an overview of this assay?(02:44) Can you talk about what genes have been added, and why?(04:16) Can you talk about patients who should have this testing?(06:20) Are there any last comments that you would like to make about the new gastrointestinal tumor panel?

Episode metadata supplied by the publisher feed · Published Nov 8, 2022

Embed this episode

Attribution link and audio player

What this episode covers

Rondell Graham, M.B.B.S., describes Mayo Clinic Laboratories' new assay for gastrointestinal stromal tumors, or GIST. The panel covers multiple mutations, to better inform diagnosis and treatment options.

Distinct summary based on available episode metadata or transcript content.

NOW PLAYING

Comprehensive panel boosts GIST diagnosis sensitivity: Rondell Graham, M.B.B.S.

0:00 8:35

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Answers from the Lab?

This episode is 8 minutes long.

When was this Answers from the Lab episode published?

This episode was published on November 8, 2022.

Can I download this Answers from the Lab episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!